A cure for the common cold?

A drug compound being developed in Australia to combat the common cold virus and associated airway infections is set to be fast-tracked The molecule is being pushed for clinical trialling after securing a multi-million dollar commercialisation boost. Respiratory research teams from Melbourne and Newcastle are employing a molecule called a TLR agonist to stimulate the